RNAC Operating Expenses

Cartesian Therapeutics Inc · Operating Expenses

RNAC logo

RNAC Operating Expenses

Latest reported$87.34M
RNAC TTM Operating Expenses ($31.32M → $87.34M)
High-resolution chart · PNG

RNAC operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Cartesian Therapeutics Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
87,339,000
80,293,000
76,705,000
79,791,000
89,032,000
86,611,000
82,810,000
101,436,000
90,088,000
76,505,000
63,012,000
43,098,000
58,254,000
77,064,000
93,951,000
95,126,000
99,752,000
94,048,000
89,674,000
83,664,000
75,648,000
72,804,000
73,418,000
72,793,000
66,207,000
66,088,000
59,132,000
55,310,000
59,457,000
61,978,000
65,925,000
69,817,000
67,757,000
64,885,000
63,991,000
61,487,000
56,122,000
48,643,000
42,753,000
35,204,000
34,366,000
33,500,000
31,315,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.